DiviDrip · URGN

URGN — UroGen Pharma Ltd. Ordinary Shares

URGN is UroGen Pharma Ltd. Ordinary Shares (Healthcare) — a non-dividend-paying stock. Trading at $44.09. Market cap: $2.19B. Capital Quality Rank: 28/100 — Capital destroyer.

Stock snapshot

Price$44.09
Market cap$2.19B
SectorHealthcare
ExchangeXNAS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)28 / 100 · Capital destroyer
Revenue CAGR (3y)19.5%
Shareholder buyback yield-10.89%
Altman Z-score zoneDistress

About URGN

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Listed2017Employees291HQRa'Anana, L3SectorHealthcareWebsiteurogen.com

Related non-dividend companies

Other non-dividend stocks investors research alongside URGN. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is URGN's current stock price?

URGN (UroGen Pharma Ltd. Ordinary Shares) is currently trading at $44.09.

Does URGN pay a dividend?

URGN (UroGen Pharma Ltd. Ordinary Shares) does not currently pay a regular dividend.

What is URGN's Capital Quality Rank?

URGN has a Capital Quality Rank of 28/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track URGN in DiviDrip

Add URGN to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow